Lv1
62 积分 2023-02-16 加入
Nanobody-based CAR T cells targeting intracellular tumor antigens
1个月前
已完结
Antibody variable region engineering for improving cancer immunotherapy
1个月前
已完结
Abstract 3434: Evaluation of TCR-engineered T cells specific for KRAS G12V mutant peptide presented by HLA-A*02:01
1个月前
已关闭
T cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial
1个月前
已完结
543 VIDAR-1: a phase 1/2a master protocol for open-label, multi-centre, single-arm, first-in-human clinical studies of autologous TCR-T therapy targeting mutant KRAS in metastatic or locally advanced PDAC
1个月前
已关闭
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
3个月前
已完结
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
4个月前
已完结
Humanization of T cell–mediated immunity in mice
4个月前
已完结
T-cell receptor gene therapy targeting KRAS G12V for advanced pancreatic cancer in a single-arm phase 1/2 clinical trial
6个月前
已完结
Antibody development and property analysis of RhBST2 for accurate cell biological and viral research
9个月前
已完结
皖公网安备34019202002308
